P70 s6 kinase inhibitor and mtor inhibitor combination therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/436 (2006.01) A61K 31/519 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2743242

The present invention provides a combination therapy comprising the compound 4- [4-[4-(4-fluoro-3-trifluo- romethyl-phenyl)-1-methyl-1H-imidazol-2-yl]-piperidin-1-yl]-1H-pyrazolo[3,4- d]pyrimidine, or a pharmaceutically acceptable salt thereof, and an mTOR inhibitor for use in the treatment of glioblastoma multiforme, adenocarcinomas of the colon, non-small-cell lung cancer, small-cell lung cancer, cisplatin-resistant small- cell lung cancer, ovarian cancer, leukemia, pancreatic cancer, prostate cancer, mammary carcinoma, renal cell carcimoma, multiple myeloma, Kaposis Sarcoma, Hodgkins lymphoma, lymphangioleiomyomatosis, Non-Hodgkins lymphoma or sarcoma.

La présente invention concerne une thérapie combinée comprenant le composé 4-[4-[4-(4-fluoro-3-trifluorométhyl-phényl)-1-méthyl-1H-imidazol-2-yl]-pipéridine-1-yl]-1H-pyrazolo[3,4-d]pyrimidine ou l'un de ses sels pharmaceutiquement admis, et un inhibiteur de mTOR. Ce composé convient au traitement du glioblastome multiforme, de l'adénocarcinome du colon, du cancer du poumon non à petites cellules, du cancer du poumon à petites cellules, du cancer du poumon à petites cellules résistant au cisplatine, du cancer des ovaires, de la leucémie, du cancer du pancréas, du cancer de la prostate, du carcinome mammaire, de l'hypernéphrome, du myélome multiple, du sarcome de Kaposi, du lymphome de Hodgkin, de la lymphangioléiomyomatose, et du lymphome ou du sarcome non de Hodgkin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

P70 s6 kinase inhibitor and mtor inhibitor combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P70 s6 kinase inhibitor and mtor inhibitor combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P70 s6 kinase inhibitor and mtor inhibitor combination therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1557266

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.